NASDAQ · LGND
Ligand Pharmaceuticals Incorporated
$319.96+$2.63 (+0.83%)
Ligand Pharmaceuticals Incorporated’s quoted price sits in the upper half of its reported 52-week range, 2.04% below the high.
Loading market information…
OTC · PHMB · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
PharmaCom BioVet, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
PharmaCom BioVet, Inc. (PHMB) operates a network of specialized treatment centers across the United States, dedicated to veterinary oncology. The company's core mission involves advancing bone marrow transplantation and various other innovative cancer therapies for companion animals, particularly those diagnosed with lymphoma, other forms of cancer, and presently incurable conditions. To mitigate suffering in animals battling cancer, PharmaCom BioVet has secured licenses for proprietary medical devices and pharmaceutical compounds. Established in 1995, the company was previously known as ABV Gold Inc. before officially changing its name to PharmaCom BioVet, Inc. in August 2008. Its corporate base is located in Raleigh, North Carolina.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:48 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$319.96+$2.63 (+0.83%)
Ligand Pharmaceuticals Incorporated’s quoted price sits in the upper half of its reported 52-week range, 2.04% below the high.
$0.30$0.00 (0.0%)
DATATRAK International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.3% below the high.
$0.50$0.00 (0.0%)
CYduct Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.76% below the high.
$0.03-$0.00 (0.0%)
Bionoid Pharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.3% below the high.
$0.18$0.00 (0.0%)
Escalon Medical Corp.’s quoted price sits in the lower half of its reported 52-week range, 37.93% below the high.
$0.00+$0.00 (+100.0%)
Herborium Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.07$0.00 (0.0%)
Mid-Atlantic Home Health Network, Inc.’s quoted price sits in the lower half of its reported 52-week range, 92.13% below the high.
$0.00$0.00 (0.0%)
Arem Pacific Corporation’s quoted price sits in the lower half of its reported 52-week range, 70.0% below the high.
